Diagnostic accuracy of intermediate b-value diffusion-weighted imaging for detection of residual hepatocellular carcinoma following transarterial chemoembolization with drug-eluting beads

Diagnostic accuracy of intermediate b-value diffusion-weighted imaging for detection of residual hepatocellular carcinoma following transarterial chemoembolization with drug-eluting beads

Purpose: To evaluate the role of diffusion-weighted magnetic resonance imaging (DW-MRI) in the detection of residual malignant tumor of hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE) with drug-eluting beads (DEBs). Subjects and Methods: Pre-contrast T1, T2, dyna...

Full description

Bibliographic Details
Main Authors:	Ahmed E Hassan, Radwa E Mostafa, Ayman Nada, Mohamed S Elazab, Ahmed Sayed Awad, Ikram M Hamed
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2019-04-01
Series:	Indian Journal of Radiology and Imaging
Subjects:	drug-eluting beads diffusion-weighted magnetic resonance imaging hepatocellular carcinoma-transcatheter arterial chemoembolization; hepatic; malignant
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.4103/ijri.IJRI_383_18

Similar Items

Role of drug-eluting beads versus conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Mahmoud Abu Elfadl, et al.
Published: (2019-01-01)

Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future
by: Hyun Young Woo, et al.
Published: (2015-12-01)

Conventional versus drug-eluting bead transarterial chemoembolization: A better option for treatment of unresectable hepatocellular carcinoma
by: Murtuza Razi, et al.
Published: (2021-02-01)

Doxorubicin-loaded drug-eluting beads versus conventional transarterial chemoembolization for nonresectable hepatocellular carcinoma
by: Mohammad Arabi, et al.
Published: (2015-01-01)

Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Apatinib Compared with Conventional Transarterial Chemoembolization Plus Apatinib in the Treatment of Unresectable Hepatocellular Carcinoma
by: Zhang W, et al.
Published: (2021-07-01)

Conventional Transarterial Chemoembolization Versus Drug-Eluting Beads in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
by: Khalid I. Bzeizi, et al.
Published: (2021-12-01)

Comparison of Clinical Efficacy and Safety between 70–150 µm and 100–300 µm Doxorubicin Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Jung Woo Yi, et al.
Published: (2022-02-01)

The impact of drug-eluting bead (vs. conventional) transarterial chemoembolization on hepatic fibrosis in treating intermediate or advanced hepatocellular carcinoma
by: Hao Li, et al.
Published: (2023-12-01)

Clinical outcomes of doxorubicin-eluting CalliSpheres® beads-transarterial chemoembolization for unresectable or recurrent esophageal carcinoma
by: Yonghua Bi, et al.
Published: (2021-05-01)

The safety and efficacy of oxaliplatin-loaded drug-eluting beads transarterial chemoembolization for the treatment of unresectable or advanced lung cancer
by: Yonghua Bi, et al.
Published: (2022-11-01)

Tumor Response and Nomogram-Based Prognostic Stratification for Hepatocellular Carcinoma After Drug-Eluting Beads Transarterial Chemoembolization
by: Ji K, et al.
Published: (2022-06-01)

Initial Experience of Drug-Eluting Bead-Transcatheter Arterial Chemoembolization After Lipiodol-Based Transcatheter Arterial Chemoembolization Failure for Patients with Advanced Hepatocellular Carcinoma
by: Liu KC, et al.
Published: (2021-10-01)

Delayed Intratumoral Hemorrhage after Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Kazue Shiozawa, et al.
Published: (2014-11-01)

Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma
by: Yi-Sheng Liu, et al.
Published: (2018-08-01)

Super-Selective Transarterial Chemoembolization with Doxorubicin-Loaded Drug-Eluting Beads Sized Below and Above 100 Microns in Hepatocellular Carcinoma: A Comparative Study
by: Huseyin Balli, et al.
Published: (2019-07-01)

CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study
by: Baolin Wu, et al.
Published: (2018-03-01)

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
by: Baur J, et al.
Published: (2016-06-01)

Efficacy of Transarterial Chemoembolization with Drug-Eluting Beads in Hepatocellular Carcinoma: A Single-Center Experience
by: Erbil Arık, et al.
Published: (2022-08-01)

A Comparison of Adverse Events Among Radiofrequency Ablation, Conventional Transarterial Chemoembolization (TACE) and Drug-Eluting Bead TACE in Treating Hepatocellular Carcinoma Patients
by: Cao G, et al.
Published: (2021-07-01)

Drug-Eluting Beads versus Lipiodol Transarterial Chemoembolization for the Treatment of Hypovascular Hepatocellular Carcinoma: A Single-Center Retrospective Study
by: Shi Q, et al.
Published: (2020-07-01)

Efficacy of transarterial chemoembolization with drug-eluting beads combined with systemic chemotherapy and targeted therapy in colorectal cancer liver metastasis
by: Yen-Cheng Chen, et al.
Published: (2023-12-01)

Callispheres drug-eluting bead transhepatic artery chemoembolization with oral delivery of sorafenib for the treatment of unresectable liver cancer
by: Wenhui Wang, et al.
Published: (2022-09-01)

Conventional or Drug-Eluting Beads? Randomized Controlled Study of Chemoembolization for Hepatocellular Carcinoma: JIVROSG-1302
by: Masafumi Ikeda, et al.
Published: (2022-06-01)

Correlation between magnetic resonance images of peritumor margin enhancement and prognosis in hepatocellular carcinoma after drug-eluting bead transcatheter arterial chemoembolization
by: Donglin Kuang, et al.
Published: (2023-04-01)

Predicting Therapeutic Efficacy of Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular Carcinoma Using Contrast-Enhanced Ultrasound
by: Kazue Shiozawa, et al.
Published: (2021-02-01)

Hepatic Arterial Chemoembolization With Arsenic Trioxide Eluting CalliSpheres Microspheres Versus Lipiodol Emulsion: Pharmacokinetics And Intratumoral Concentration In A Rabbit Liver Tumor Model
by: Duan X, et al.
Published: (2019-11-01)

Retrospective analysis of efficacy, safety, and prognostic factors in a cohort of Chinese hepatocellular carcinoma patients treated with drug-eluting bead transarterial chemoembolization
by: Sihan Chen, et al.
Published: (2019-11-01)

Transarterial chemoembolization as a part of multi-modality treatment with drug-eluting beads for locally advanced breast cancer: A case report
by: Jau-Nan Lin, et al.
Published: (2021-11-01)

Effects of HepaSphere microsphere encapsule epirubicin with a new loading method transarterial chemoembolization: in vitro and in vivo experiments
by: Wen Zhang, et al.
Published: (2023-11-01)

Drug-Eluting Bead Transarterial Chemoembolization Combined with FOLFOX-Based Hepatic Arterial Infusion Chemotherapy for Large or Huge Hepatocellular Carcinoma
by: Huang J, et al.
Published: (2021-11-01)

Prediction of initial objective response to drug-eluting beads transcatheter arterial chemoembolization for hepatocellular carcinoma using CT radiomics-based machine learning model
by: Xueying Zhang, et al.
Published: (2024-01-01)

Survival of patients with intermediate stage hepatocellular carcinoma treated with superselective transarterial chemoembolization using doxorubicin-loaded DC Bead under cone-beam computed tomography control
by: Popovic Peter, et al.
Published: (2016-12-01)

The Influence of Drug-Eluting Beads Transarterial Chemoembolization on Serum Levels of Soluble Programmed Cell Death Protein-1 in Advanced Hepatocellular Carcinoma Patients
by: Ma X, et al.
Published: (2024-03-01)

Safety and Efficacy of Drug-Eluting Bead Transarterial Chemoembolization Combined with Lenvatinib and Anti-PD-1 Antibodies for Unresectable Hepatocellular Carcinoma: A Retrospective Analysis
by: Wu SJ, et al.
Published: (2023-06-01)

Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres
by: Waleed M. Hetta, et al.
Published: (2014-09-01)

Irinotecan drug eluting beads used as a treatment of advanced intra hepatic cholangiocarcinoma
by: Jean Amede Roch, et al.
Published: (2008-10-01)

Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Fateen W, et al.
Published: (2017-10-01)

Callispheres® drug-eluting beads transarterial chemoembolization might be an efficient and safety down-staging therapy in unresectable liver cancer patients
by: Ning Peng, et al.
Published: (2022-08-01)

Treatment Strategy of Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Shiro Miyayama
Published: (2020-10-01)

Clinical outcomes of gemcitabine-loaded callispheres drug-eluting beads for patients with advanced and inoperable lung cancer: A case series study
by: Yonghua Bi, et al.
Published: (2022-09-01)